tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Geulah Livshits, 196 are a BUY (97.03%), 6 are a HOLD (2.97%).
Analyst Geulah Livshits, currently employed at CHARDAN CAPITAL, carries an average stock price target met ratio of 32.04% that have a potential upside of 41.8% achieved within 138 days.
Geulah Livshits’s has documented 355 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TSHA, Taysha Gene Therapies at 16-Oct-2025.
Analyst best performing recommendations are on RCKT (ROCKET PHARMACEUTICALS).
The best stock recommendation documented was for RCKT (ROCKET PHARMACEUTICALS) at 12/8/2020. The price target of $46 was fulfilled within 1 day with a profit of $13.97 (43.62%) receiving and performance score of 436.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$93
$25.39 (37.55%)
$78
13 days ago
(16-Oct-2025)
2/6 (33.33%)
$23.85 (34.49%)
32
Buy
$81
$13.39 (19.80%)
$81
20 days ago
(09-Oct-2025)
8/24 (33.33%)
$7.93 (10.85%)
214
Buy
$80
$12.39 (18.33%)
$80
1 months 7 days ago
(22-Sep-2025)
4/6 (66.67%)
$19.24 (31.67%)
100
Hold
$56
$-11.61 (-17.17%)
$42
2 months 24 days ago
(05-Aug-2025)
15/18 (83.33%)
$-0.34 (-0.60%)
131
Hold
$42
$-25.61 (-37.88%)
$38
2 months 25 days ago
(04-Aug-2025)
12/14 (85.71%)
$-13.59 (-24.45%)
164
Which stock is Geulah Livshits is most bullish on?
Which stock is Geulah Livshits is most reserved on?
What Year was the first public recommendation made by Geulah Livshits?
